TY - JOUR
T1 - Development of a UPLC-MS/MS method for the quantification of sildenafil by DBS, and its use on pediatric pulmonary hypertension
AU - Zavala, Leticia Contreras
AU - Espinosa, Liliana Rivera
AU - Moreno, Alionka P.Ángeles
AU - San-Juan, Eduardo Ramírez
AU - Hernández, Sergio Zamudio
AU - González, Alberto García
AU - Jiménez, Gabriel Marcelín
N1 - Publisher Copyright:
© 2014 Future Science Ltd.
PY - 2014/11/1
Y1 - 2014/11/1
N2 - Background: Sildenafil is used for the treatment of pediatric pulmonary hypertension. A dried blood spot (DBS)-based LC-MS method for sildenafil quantitation was developed and applied to a group of patients. Results: DBS showed high portability and stability of samples, and the method was selective and linear for quantitation of sildenafil (5-3,000 ng/ml) and N-desmethyl-sildenafil (3-1,500 ng/ml). After a single oral dose of sildenafil (1 mg/kg), method evidenced poor metabolism in these patients.Conclusion: The method was successfully applied in peripheral blood and can be used for both pharmacokinetics and therapeutic drug monitoring. DBS proved to have advantages during sample translation and preservation of analytes. Data suggest that hazardous blood sildenafil levels may be reached in this population.
AB - Background: Sildenafil is used for the treatment of pediatric pulmonary hypertension. A dried blood spot (DBS)-based LC-MS method for sildenafil quantitation was developed and applied to a group of patients. Results: DBS showed high portability and stability of samples, and the method was selective and linear for quantitation of sildenafil (5-3,000 ng/ml) and N-desmethyl-sildenafil (3-1,500 ng/ml). After a single oral dose of sildenafil (1 mg/kg), method evidenced poor metabolism in these patients.Conclusion: The method was successfully applied in peripheral blood and can be used for both pharmacokinetics and therapeutic drug monitoring. DBS proved to have advantages during sample translation and preservation of analytes. Data suggest that hazardous blood sildenafil levels may be reached in this population.
UR - http://www.scopus.com/inward/record.url?scp=84918495986&partnerID=8YFLogxK
U2 - 10.4155/bio.14.126
DO - 10.4155/bio.14.126
M3 - Artículo
C2 - 25486229
SN - 1757-6180
VL - 6
SP - 2815
EP - 2824
JO - Bioanalysis
JF - Bioanalysis
IS - 21
ER -